logo

For the Inventor, By the Inventor

Chestnut Hill, MA, United States of America

Frank G Oppenheim

This inventor holds 9 USPTO granted patents. Top assignees: Boston University, Periodontix, Inc., Other. Active years: 1996-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank G Oppenheim. Retrieved from https://idiyas.com/inventor/frank-g-oppenheim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 77.8

Average Co-Inventor Count = 2.8

ph-index = 6

Forward Citations = 132(Granted Patents)


Company Filing History:

goldMedal8 out of 833 
 
Boston University
 patents
silverMedal4 out of 5 
 
Periodontix, Inc.
 patents
bronzeMedal1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1996-2017

Loading Chart...
9 patents (USPTO):Explore Patents
1. 9598684 - [object Object] (2017-03-21),
2. 8685392 - [object Object] (2014-04-01),
3. 6531573 - Antifungal and antibacterial peptides (2003-03-11),
4. 5912230 - Anti-fungal and anti-bacterial histatin-based peptides (1999-06-15),
5. 5885965 - Anti-fungal D-amino acid histatin-based peptides (1999-03-23),
6. 5696078 - Methods of treating fungal infections using histatin-based peptides (1997-12-09),
7. 5646119 - D-amino acid histatin-based peptides as anti-fungal and anti-bacterial (1997-07-08),
8. 5631228 - Anti-fungal and anti-bacterial histatin-based peptides (1997-05-20),
9. 5486503 - Anti-fungal histatin-based peptides (1996-01-23),

Title: Frank G Oppenheim: Innovator in Gluten-Degrading Enzymes

Introduction

Frank G Oppenheim is a notable inventor based in Chestnut Hill, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of gluten-degrading enzymes. With a total of 9 patents to his name, Oppenheim's work has the potential to impact the treatment of gluten-related disorders.

Latest Patents

Oppenheim's latest patents focus on innovative solutions for gluten degradation. One of his inventions involves gluten-degrading enzymes found in specific bacteria that can break peptide bonds in peptides containing sequences such as -XPQ-, -QQP-, -PPF-, -LYP-, and/or -PFP-. These enzymes are characterized as acidic, retaining protease activity at low pH levels, such as 3.0, and having isoelectric points ranging from 2.0 to 7.0. His work provides isolated enzyme compositions and probiotic formulations that include at least one acidic gluten-degrading enzyme. Additionally, he has developed methods for treating celiac disease and related disorders, as well as for degrading and detoxifying gluten in food products.

Another significant patent relates to glutamine endopeptidase enzymes derived from bacteria naturally associated with the oral cavity. This invention includes formulations containing these enzymes and their application in the treatment and prevention of allergic reactions, particularly for gluten allergy-related diseases such as Celiac Sprue and dermatitis herpetiformis.

Career Highlights

Throughout his career, Frank G Oppenheim has worked with esteemed institutions, including Boston University and Periodontix, Inc. His research has contributed to advancements in the understanding and treatment of gluten-related health issues.

Collaborations

Oppenheim has collaborated with notable colleagues, including Tao Xu and F Donald Roberts, further enhancing the impact of his research and inventions.

Conclusion

Frank G Oppenheim's innovative work in gluten-degrading enzymes showcases his commitment to addressing significant health challenges. His contributions have the potential to improve the lives of individuals affected by gluten-related disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…